Answer
Ocrevus (ocrelizumab) is indicated for adults with relapsing forms of multiple sclerosis with active disease defined by clinical or imaging features.
Sources for this answer
- OCREVUS 300 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 20Document updated
Sources checked